The effects of adriamycin and daunomycin on antitumoral immune effector mechanisms in an allogeneic system.
D000818:Animals; D000912:Antibodies, Neoplasm / Q000032:analysis; D000917:Antibody Formation / Q000187:drug effects; D001202:Ascitic Fluid / Q000166:cytology; D003601:Cytotoxicity Tests, Immunologic; D003630:Daunorubicin / Q000494:pharmacology*; D004317:Doxorubicin / Q000494:pharmacology*; D005260:Female; D006084:Graft Rejection / Q000187:drug effects*; D007111:Immunity, Cellular / Q000187:drug effects; D007939:Leukemia L1210 / Q000276:immunology*; D051379:Mice; D008809:Mice, Inbred C3H; D014184:Transplantation, Homologous
D000912:Antibodies, Neoplasm; D004317:Doxorubicin; D003630:Daunorubicin